Robinson James A. Jr.
Insider CIK 1734295 · AGTC Director · ELDN Director · NEOS Director · ALKS President & COO,Alkermes, Inc. · URGN Director · UROV PEO;CEO/Urovant Sciences, Inc., Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| ELDN Eledon Pharmaceuticals, In | A Award deriv | 2035-01-10 | 2025-01-13 | 30,870 | — | $0 | 30,870 | SEC↗ |
| URGN UroGen Pharma Ltd. | M Exercise deriv | 2026-08-26 | 2026-08-28 | 2,000 | — | $0 | 0 | SEC↗ |
| URGN UroGen Pharma Ltd. | M Exercise | 2026-08-26 | 2026-08-28 | 2,000 | — | $0 | 8,000 | SEC↗ |
| URGN UroGen Pharma Ltd. | M Exercise deriv | 2026-08-26 | 2026-08-28 | 2,000 | — | $0 | 0 | SEC↗ |
| URGN UroGen Pharma Ltd. | M Exercise | 2026-08-26 | 2026-08-28 | 2,000 | — | — | 8,000 | SEC↗ |
| URGN UroGen Pharma Ltd. | A Award deriv | 2026-06-22 | 2026-06-24 | 8,000 | — | $0 | 8,000 | SEC↗ |
| URGN UroGen Pharma Ltd. | A Award deriv | 2026-06-22 | 2026-06-24 | 10,000 | — | $0 | 10,000 | SEC↗ |
| URGN UroGen Pharma Ltd. | M Exercise deriv | 2026-05-26 | 2026-05-27 | 2,000 | — | $0 | 2,000 | SEC↗ |
| URGN UroGen Pharma Ltd. | M Exercise | 2026-05-26 | 2026-05-27 | 2,000 | — | $0 | 6,000 | SEC↗ |
| ELDN Eledon Pharmaceuticals, In | M Exercise deriv | 2026-01-10 | 2026-01-16 | 3,430 | — | $0 | 0 | SEC↗ |
| ELDN Eledon Pharmaceuticals, In | M Exercise | 2026-01-10 | 2026-01-16 | 3,430 | — | $0 | 3,430 | SEC↗ |
| URGN UroGen Pharma Ltd. | M Exercise deriv | 2025-11-26 | 2025-12-01 | 2,000 | — | $0 | 6,000 | SEC↗ |
| URGN UroGen Pharma Ltd. | M Exercise | 2025-11-26 | 2025-12-01 | 2,000 | — | $0 | 2,000 | SEC↗ |
| URGN UroGen Pharma Ltd. | A Award deriv | 2025-08-26 | 2025-08-27 | 8,000 | — | $0 | 8,000 | SEC↗ |
| URGN UroGen Pharma Ltd. | A Award deriv | 2025-08-26 | 2025-08-27 | 10,000 | — | $0 | 10,000 | SEC↗ |
| URGN UroGen Pharma Ltd. | M Exercise deriv | 2025-02-26 | 2026-02-27 | 2,000 | — | $0 | 4,000 | SEC↗ |
| URGN UroGen Pharma Ltd. | M Exercise | 2025-02-26 | 2026-02-27 | 2,000 | — | $0 | 4,000 | SEC↗ |
| ELDN Eledon Pharmaceuticals, In | A Award deriv | 2025-01-10 | 2025-01-13 | 3,430 | — | $0 | 3,430 | SEC↗ |
| URGN UroGen Pharma Ltd. | A Award deriv | 2024-08-06 | 2024-08-08 | 10,000 | — | $0 | 10,000 | SEC↗ |
| ELDN Eledon Pharmaceuticals, In | A Award deriv | 2023-10-02 | 2023-10-03 | 150,437 | $1.55 | $233.2K | 150,437 | SEC↗ |
| URGN UroGen Pharma Ltd. | A Award deriv | 2023-09-07 | 2023-09-08 | 10,000 | — | $0 | 10,000 | SEC↗ |
| URGN UroGen Pharma Ltd. | A Award deriv | 2023-07-25 | 2023-07-27 | 20,000 | — | $0 | 20,000 | SEC↗ |
| URGN UroGen Pharma Ltd. | A Award deriv | 2023-07-25 | 2023-07-28 | 20,000 | — | $0 | 20,000 | SEC↗ |
| AGTC APPLIED GENETIC TECHNOLOGI | D To issuer deriv | 2022-11-30 | 2022-12-01 | 25,000 | — | $0 | 0 | SEC↗ |
| AGTC APPLIED GENETIC TECHNOLOGI | A Award deriv | 2021-11-30 | 2021-12-02 | 25,000 | — | $0 | 25,000 | SEC↗ |
| UROV Urovant Sciences Ltd. | D To issuer deriv | 2021-03-29 | 2021-03-31 | 845,732 | — | $0 | 0 | SEC↗ |
| UROV Urovant Sciences Ltd. | D To issuer deriv | 2021-03-29 | 2021-03-31 | 50,000 | — | $0 | 0 | SEC↗ |
| UROV Urovant Sciences Ltd. | D To issuer deriv | 2021-03-29 | 2021-03-31 | 25,000 | — | $0 | 0 | SEC↗ |
| UROV Urovant Sciences Ltd. | D To issuer | 2021-03-29 | 2021-03-31 | 8,385 | — | $0 | 0 | SEC↗ |
| NEOS Neos Therapeutics, Inc. | D To issuer deriv | 2021-03-19 | 2021-03-19 | 12,500 | — | $0 | 0 | SEC↗ |
| NEOS Neos Therapeutics, Inc. | D To issuer deriv | 2021-03-19 | 2021-03-19 | 46,907 | — | $0 | 0 | SEC↗ |
| NEOS Neos Therapeutics, Inc. | D To issuer | 2021-03-19 | 2021-03-19 | 23,453 | — | $0 | 0 | SEC↗ |
| UROV Urovant Sciences Ltd. | F Tax w/h | 2021-01-10 | 2021-01-12 | 4,095 | $16.11 | $66.0K | 8,385 | SEC↗ |
| NEOS Neos Therapeutics, Inc. | A Award | 2020-06-10 | 2020-06-11 | 23,453 | — | $0 | 23,453 | SEC↗ |
| UROV Urovant Sciences Ltd. | A Award deriv | 2020-03-23 | 2020-03-25 | 845,732 | — | $0 | 845,732 | SEC↗ |
| UROV Urovant Sciences Ltd. | A Award | 2020-01-10 | 2020-01-14 | 12,480 | — | $0 | 12,480 | SEC↗ |
| UROV Urovant Sciences Ltd. | A Award deriv | 2019-07-09 | 2019-07-11 | 25,000 | — | $0 | 25,000 | SEC↗ |
| NEOS Neos Therapeutics, Inc. | A Award deriv | 2019-06-13 | 2019-06-17 | 46,907 | — | $0 | 46,907 | SEC↗ |
| ALKS Alkermes plc. | M Exercise deriv | 2019-04-04 | 2019-04-05 | 6,250 | — | $0 | 18,750 | SEC↗ |
| ALKS Alkermes plc. | F Tax w/h | 2019-04-04 | 2019-04-05 | 1,838 | $35.89 | $66.0K | 4,412 | SEC↗ |
| ALKS Alkermes plc. | M Exercise | 2019-04-04 | 2019-04-05 | 6,250 | — | $0 | 6,250 | SEC↗ |
| UROV Urovant Sciences Ltd. | A Award deriv | 2019-03-01 | 2019-03-05 | 50,000 | — | $0 | 50,000 | SEC↗ |
| ALKS Alkermes plc. | A Award deriv | 2019-02-21 | 2019-02-25 | 40,400 | — | $0 | 40,400 | SEC↗ |
| ALKS Alkermes plc. | A Award deriv | 2019-02-21 | 2019-02-25 | 157,000 | — | $0 | 157,000 | SEC↗ |
| NEOS Neos Therapeutics, Inc. | A Award deriv | 2019-01-29 | 2019-01-30 | 12,500 | — | $0 | 12,500 | SEC↗ |
| ALKS Alkermes plc. | A Award deriv | 2018-04-04 | 2018-07-03 | 140,000 | $44.16 | $6.18M | 140,000 | SEC↗ |
| ALKS Alkermes plc. | A Award deriv | 2018-04-04 | 2018-07-03 | 25,000 | — | $0 | 25,000 | SEC↗ |